MEF2D and Parkinson disease: Myocyte enhancer factor 2D (MEF2D) functions as a transcriptional activator that binds mt-DNA sections encoding complex I subunit NADH dehydrogenase, whose down-regulation in mouse models and post-mortem PD brains is associated with increased hydrogen peroxide levels, low ATP production and stress-induced cell death [75].